UFP Technologies Inc. is a prominent player in the field of engineered foam products, primarily specializing in the design and manufacture of innovative custom conversion solutions for a diversified range of markets. Its primary function is to deliver high-performance packaging, components, and products made from foams, plastics, and natural fibers. UFP Technologies serves critical sectors including medical, automotive, aerospace, defense, and industrial industries, impacting these sectors by providing essential protective and functional solutions. Additionally, the company’s expertise in materials and in-depth understanding of customer requirements enable it to design tailored solutions that meet stringent specifications, thereby enhancing the performance and safety of its clients' products. With a focus on sustainability, UFP Technologies also incorporates recycled and eco-friendly materials into its offerings. As a player deeply integrated in the supply chains of critical industries, UFP Technologies plays a substantial role in advancing packaging and component technologies, contributing to the efficiency and innovation within its served markets.
Website100 Hale Street
Newburyport, MA, 01950-3504
United States
UFP Technologies has seen a powerful run in its share price in recent years, which naturally raises a question for anyone looking at the stock today. Is the current valuation supported by the company’s earnings, or has sentiment moved ahead of the underlying profit stream? Over the past 5 years, UFP Technologies has delivered a total return of about 3.8x, which puts real pressure on the current earnings multiple to carry that track record forward. The business leans heavily on specialized...
Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the letter here. The Tributary Multi Cap Core’s equity allocation underperformed in Q2, returning +12.5% against +15.3% for the S&P 1500 and +15.4% for the Russell 3000. Information Technology was the main driver of […]
Detailed price information for Cintas Corp (CTAS-Q) from The Globe and Mail including charting and trades.
Veracyte, Globus Medical and UFP Technologies are positioned to benefit as GenAI adoption reshapes medical instruments.
Investors need to pay close attention to UFPT stock based on the movements in the options market lately.
On August 3, UFP Technologies (NASDAQ:UFPT) reported second-quarter net income of $20.9 million, up 21.4% from $17.2 million a year earlier, alongside net sales of $174.0 million, a 15.1% jump from $151.2 million. Both figures, along with adjusted earnings per share of $2.92, marked the best quarter in the company’s history. For the six months […]
Investors talking about UFPT also mention
| # | Name | Attention |
|---|---|---|
| 1 | A SPAC III Acquisition Corp.ASPCU | 0%0 |
| 2 | Nurix Therapeutics, Inc.NRIX | 0%new |
| 3 | BioAge Labs, Inc.BIOA | 0.01%+0 |
| 4 | MeiraGTx Holdings plcMGTX | 0%new |
| 5 | James Hardie Industries plcJHX | 0%new |
| 6 | Standex International CorporationSXI | 0%new |
| 7 | Insight Enterprises, Inc.NSIT | 0%0 |
| 8 | Denali Therapeutics Inc.DNLI | 0%new |
| 9 | Trevi Therapeutics, Inc.TRVI | 0%new |
| 10 | Arcus Biosciences, Inc.RCUS | 0%new |
What share of all stock conversation is about UFPT?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% new | 0% 0 | 0% 0 |
Of the messages about UFPT that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 100% | 100% 0 | 97.6% +48.1 | ||
| Bearish | — | 0% | 0% 0 | 2.4% -48.1 |
Of the messages about UFPT that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | — | 50% | 50% | 58.27% | ||
| Announcements | — | 50% | 50% | 12.23% | ||
| Earnings | — | 0% | 0% | 8.63% | ||
| Analysts | — | 0% | 0% | 10.79% | ||
| Controversies | — | 0% | 0% | 0% | ||
| Macro | — | 0% | 0% | 10.07% |
Of the messages about UFPT, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 0% | 0% | 37.39% | ||
| Newcomers | — | 100% | 100% | 62.61% |